Molecular activities of vitamin E

Phytochemicals: Nutrient-Gene Interactions

Volumn , Issue , 2006, Pages 175-206

  Zingg, Jean Marc ^a   Azzi, Angelo ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 35448992614     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (209)

1. Evans, H.M. and Bishop, K.S., On the existence of a hitherto unrecognized dietary factor essential for reproduction, Science 56, 650-651, 1922.
2. Ingold, K.U., Bowry, V.W., Stocker, R., and Walling, C., Autoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein, Proc. Natl. Acad. Sci. U.S.A. 90 (1), 45-49, 1993.
3. Niki, E., Interaction of ascorbate and alpha-tocopherol, Ann. N. Y. Acad. Sci. 498, 186-99, 1987.
4. Smith, D., O’Leary, V.J., and Darley-Usmar, V.M., The role of alpha-tocopherol as a peroxyl radical scavenger in human low density lipoprotein, Biochem. Pharmacol. 45 (11), 2195-2201, 1993.
5. Ricciarelli, R., Zingg, J.M., and Azzi, A., Vitamin E: protective role of a Janus molecule, FASEB. J. 15 (13), 2314-2325, 2001.
6. Brigelius-Flohe, R., Kelly, F.J., Salonen, J.T., Neuzil, J., Zingg, J.M., and Azzi, A., The European perspective on vitamin E: current knowledge and future research, Am. J. Clin. Nutr. 76 (4), 703-716, 2002.
7. Rimbach, G., Minihane, A.M., Majewicz, J., Fischer, A., Pallauf, J., Virgli, F., and Weinberg, P.D., Regulation of cell signalling by vitamin E, Proc. Nutr. Soc 61 (4), 415-425, 2002.
8. Zingg, J.M. and Azzi, A., Non-antioxidant activities of vitamin E, Cur. Med. Chem. 11 (9), 1113-1133, 2004.
9. Koch, M., Lemke, R., Heise, K.P., and Mock, H.P., Characterization of gammatocopherol methyltransferases from Capsicum annuum L and Arabidopsis thaliana, Eur. J. Biochem. 270 (1), 84-92, 2003.
10. Ajjawi, I. and Shintani, D., Engineered plants with elevated vitamin E: a nutraceutical success story, Trends Biotechnol. 22 (3), 104-107, 2004.
11. Shintani, D. and DellaPenna, D., Elevating the vitamin E content of plants through metabolic engineering, Science 282 (5396), 2098-2100, 1998.
12. Van Eenennaam, A.L., Lincoln, K., Durrett, T.P., Valentin, H.E., Shewmaker, C.K., Thorne, G.M., Jiang, J., Baszis, S.R., Levering, C.K., Aasen, E.D., Hao, M., Stein, J.C., Norris, S.R., and Last, R.L., Engineering vitamin E content: from Arabidopsis mutant to soy oil, Plant Cell 15 (12), 3007-3019, 2003.
13. Porfirova, S., Bergmuller, E., Tropf, S., Lemke, R., and Dormann, P., Isolation of an Arabidopsis mutant lacking vitamin E and identification of a cyclase essential for all tocopherol biosynthesis, Proc. Natl. Acad. Sci. U.S.A. 99 (19), 12495-12500, 2002.
14. Demmig-Adams, B. and Adams, W.W., 3rd, Antioxidants in photosynthesis and human nutrition, Science 298 (5601), 2149-2153, 2002.
15. Sattler, S.E., Cahoon, E.B., Coughlan, S.J., and DellaPenna, D., Characterization of tocopherol cyclases from higher plants and cyanobacteria. Evolutionary implications for tocopherol synthesis and function, Plant Physiol. 132 (4), 2184-2195, 2003.
16. Hofius, D. and Sonnewald, U., Vitamin E biosynthesis: biochemistry meets cell biology, Trends Plant Sci. 8 (1), 6-8, 2003.
17. Hofius, D., Hajirezaei, M.R., Geiger, M., Tschiersch, H., Melzer, M., and Sonnewald, U., RNAi-mediated tocopherol deficiency impairs photoassimilate export in transgenic potato plants, Plant. Physiol. 135 (3), 1256-1268, 2004.
18. Munne-Bosch, S. and Falk, J., New insights into the function of tocopherols in plants, Planta 218 (3), 323-326, 2004.
19. Munne-Bosch, S., Linking tocopherols with cellular signaling in plants, New Phytol. 166 (2), 363-366, 2005.
20. Schneider, C., Chemistry and biology of vitamin E, Mol Nutr Food Res 49 (1), 7-30, 2005.
21. Ogru, E., Gianello, R., Libinaki, R., Smallridge, A., Bak, R., Geytenbeck, S., Kannar, D., and West, S., in Free Radicals and Oxidative Stress: Chemistry, Biochemistry and Pathophysiological Implications, Galaris, D., Ed., Medimond, Bologna, 2003, pp. 109-113.
22. Xie, Z. and Sastry, B.R., Induction of hippocampal long-term potentiation by alphatocopherol, Brain Res. 604 (1-2), 173-179, 1993.
23. Nakayama, S., Katoh, E.M., Tsuzuki, T., and Kobayashi, S., Protective effect of alphatocopherol-6-O-phosphate against ultraviolet B-induced damage in cultured mouse skin, J. Invest. Dermatol. 121 (2), 406-411, 2003.
24. Sakai, T., Okano, T., Makino, H., and Tsudzuki, T., Activation of cyclic AMP phosphodiesterase by a new vitamin E derivative, J. Cyclic Nucleotide Res. 2 (3), 163-170, 1976.
25. Abita, J.P., Parniak, M., and Kaufman, S., The activation of rat liver phenylalanine hydroxylase by limited proteolysis, lysolecithin, and tocopherol phosphate. Changes in conformation and catalytic properties, J. Biol. Chem. 259 (23), 14560-14566, 1984.
26. Munteanu, A., Zingg, J.M., Ogru, E., Libinaki, R., Gianello, R., West, S., Negis, Y., and Azzi, A., Modulation of cell proliferation and gene expression by alpha-tocopheryl phosphates: relevance to atherosclerosis and inflammation, Biochem. Biophys. Res. Commun. 318 (1), 311-316, 2004.
27. Negis, Y., Zingg, J.M., Ogru, E., Gianello, R., Libinaki, R., and Azzi, A., On the existence of cellular tocopheryl phosphate, its synthesis, degradation and cellular roles: a hypothesis, IUBMB Life 57 (1), 23-25, 2005.
28. Kempna, P., Reiter, E., Arock, M., Azzi, A., and Zingg, J.M., Inhibition of HMC-1 mast cell proliferation by vitamin E: involvement of the protein kinase B pathway, J. Biol. Chem. 279 (49), 50700-50709, 2004.
29. Lien, E.J., Ren, S., Bui, H.H., and Wang, R., Quantitative structure-activity relationship analysis of phenolic antioxidants, Free Radic. Biol. Med. 26 (3-4), 285-294, 1999.
30. Kaiser, S., Di Mascio, P., Murphy, M.E., and Sies, H., Physical and chemical scavenging of singlet molecular oxygen by tocopherols, Arch. Biochem. Biophys. 277 (1), 101-108, 1990.
31. Kamal-Eldin, A. and Appelqvist, L.A., The chemistry and antioxidant properties of tocopherols and tocotrienols, Lipids 31 (7), 671-701, 1996.
32. Rezk, B.M., Haenen, G.R., Van Der Vijgh, W.J., and Bast, A., The extraordinary antioxidant activity of vitamin E phosphate, Biochim. Biophys. Acta 1683 (1-3), 16-21, 2004.
33. Traber, M.G. and Kayden, H.J., Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins, Am. J. Clin. Nutr. 49 (3), 517-526, 1989.
34. Brigelius-Flohe, R. and Traber, M.G., Vitamin E: function and metabolism, FASEB. J. 13 (10), 1145-1155, 1999.
35. Muller, D.P., Manning, J.A., Mathias, P.M., and Harries, J.T., Studies on the intestinal hydrolysis of tocopheryl esters, Int. J. Vitam. Nutr. Res. 46 (2), 207-210, 1976.
36. Mathias, P.M., Harries, J.T., Peters, T.J., and Muller, D.P., Studies on the in vivo absorption of micellar solutions of tocopherol and tocopheryl acetate in the rat: demonstration and partial characterization of a mucosal esterase localized to the endoplasmic reticulum of the enterocyte, J. Lipid. Res. 22 (5), 829-837, 1981.
37. Nierenberg, D.W., Lester, D.C., and Colacchio, T.A., Determination of tocopherol and tocopherol acetate concentrations in human feces using high-performance liquid chromatography, J. Chromatogr. 413, 79-89, 1987.
38. Lauridsen, C., Hedemann, M.S., and Jensen, S.K., Hydrolysis of tocopheryl and retinyl esters by porcine carboxyl ester hydrolase is affected by their carboxylate moiety and bile acids, J. Nutr. Biochem. 12 (4), 219-224, 2001.
39. Sokol, R.J., Heubi, J.E., Butler-Simon, N., McClung, H.J., Lilly, J.R., and Silverman, A., Treatment of vitamin E deficiency during chronic childhood cholestasis with oral d-alpha-tocopheryl polyethylene glycol-1000 succinate, Gastroenterology 93 (5), 975-985, 1987.
40. Sokol, R.J., Butler-Simon, N., Conner, C., Heubi, J.E., Sinatra, F.R., Suchy, F.J., Heyman, M.B., Perrault, J., Rothbaum, R.J., Levy, J. et al., Multicenter trial of dalpha- tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis, Gastroenterology 104 (6), 1727-1735, 1993.
41. Mori, Y., Hatamochi, A., Takeda, K., and Ueki, H., Effects of tretinoin tocoferil on gene expression of the extracellular matrix components in human dermal fibroblasts in vitro, J. Dermatol. Sci. 8 (3), 233-238, 1994.
42. Funasaka, Y., Chakraborty, A.K., Komoto, M., Ohashi, A., and Ichihashi, M., The depigmenting effect of alpha-tocopheryl ferulate on human melanoma cells, Br. J. Dermatol. 141 (1), 20-29, 1999.
43. Birringer, M., EyTina, J.H., Salvatore, B.A., and Neuzil, J., Vitamin E analogues as inducers of apoptosis: structure-function relation, Br. J. Cancer 88 (12), 1948-1955, 2003.
44. Kline, K., Yu, W., and Sanders, B.G., Vitamin E and breast cancer, J. Nutr. 134 (12 Suppl), 3458S-3462S, 2004.
45. Wu, Y., Zu, K., Ni, J., Yeh, S., Kasi, D., James, N. S., Chemler, S., and Ip, C., Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention, Anticancer Res. 24 (6), 3795-3802, 2004.
46. Drevon, C.A., Absorption, transport and metabolism of vitamin E, Free. Radic. Res. Commun. 14 (4), 229-246, 1991.
47. Cheeseman, K.H., Holley, A.E., Kelly, F.J., Wasil, M., Hughes, L., and Burton, G., Biokinetics in humans of RRR-alpha-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E, Free Radic. Biol. Med. 19 (5), 591-598, 1995.
48. Burton, G.W., Traber, M.G., Acuff, R.V., Walters, D.N., Kayden, H., Hughes, L., and Ingold, K.U., Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E, Am. J. Clin. Nutr. 67 (4), 669-684, 1998.
49. Neuzil, J., Weber, T., Terman, A., Weber, C., and Brunk, U.T., Vitamin E analogues as inducers of apoptosis: implications for their potential antineoplastic role, Redox. Rep. 6 (3), 143-151, 2001.
50. Neuzil, J., Weber, T., Schroder, A., Lu, M., Ostermann, G., Gellert, N., Mayne, G.C., Olejnicka, B., Negre-Salvayre, A., Sticha, M., Coffey, R.J., and Weber, C., Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements, FASEB. J. 15 (2), 403-415., 2001.
51. Smith, R.A.J., Porteous, C.M., Gane, A.M., and Murphy, M.P., Delivery of bioactive molecules to mitochondria in vivo, Proc. Natl. Acad. Sci. U.S.A. 100 (9), 5407-5412, 2003.
52. Simon, E.J., The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of alpha-tocopherol., J. Biol. Chem. 221, 807-817, 1956.
53. Simon, E.J., Gross, C.S., and Milhorat, A.T., The metabolism of vitamin E. The absorption and excretion of d-α-tocopheryl-5-methyl-C14-succinate, J. Biol. Chem. 221, 797-805, 1956.
54. Brigelius-Flohe, R., Vitamin E and drug metabolism, Biochem. Biophys. Res. Commun. 305 (3), 737-740, 2003.
55. Schultz, M., Leist, M., Petrzika, M., Gassmann, B., and Brigelius-Flohe, R., Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6- hydroxychroman, as an indicator of an adequate vitamin E supply?, Am. J. Clin. Nutr. 62 (6 Suppl), 1527S-1534S, 1995.
56. Chiku, S., Hamamura, K., and Nakamura, T., Novel urinary metabolite of d-deltatocopherol in rats, J. Lipid. Res. 25 (1), 40-48, 1984.
57. Wechter, W.J., Kantoci, D., Murray, E.D., Jr., D’Amico, D.C., Jung, M.E., and Wang, W.H., A new endogenous natriuretic factor: LLU-alpha, Proc. Natl. Acad. Sci. U.S.A. 93 (12), 6002-6007, 1996.
58. Lemcke-Norojarvi, M., Kamal-Eldin, A., Appelqvist, L.A., Dimberg, L.H., Ohrvall, M., and Vessby, B., Corn and sesame oils increase serum gamma-tocopherol concentrations in healthy Swedish women, J. Nutr. 131 (4), 1195-1201, 2001.
59. Parker, R.S., Sontag, T.J., and Swanson, J.E., Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin, Biochem. Biophys. Res. Commun. 277 (3), 531-534, 2000.
60. Birringer, M., Drogan, D., and Brigelius-Flohe, R., Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation, Free Radic. Biol. Med. 31 (2), 226-232, 2001.
61. Himmelfarb, J., Kane, J., McMonagle, E., Zaltas, E., Bobzin, S., Boddupalli, S., Phinney, S., and Miller, G., Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease, Kidney Int. 64 (3), 978-991, 2003.
62. Grammas, P., Hamdheydari, L., Benaksas, E.J., Mou, S., Pye, Q.N., Wechter, W.J., Floyd, R.A., Stewart, C., and Hensley, K., Anti-inflammatory effects of tocopherol metabolites, Biochem. Biophys. Res. Commun. 319 (3), 1047-1052, 2004.
63. Hensley, K., Benaksas, E.J., Bolli, R., Comp, P., Grammas, P., Hamdheydari, L., Mou, S., Pye, Q.N., Stoddard, M.F., Wallis, G., Williamson, K.S., West, M., Wechter, W.J., and Floyd, R.A., New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine, Free Radic Biol Med 36 (1), 1-15, 2004.
64. Murray, E.D., Jr., Wechter, W.J., Kantoci, D., Wang, W.H., Pham, T., Quiggle, D.D., Gibson, K.M., Leipold, D., and Anner, B.M., Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha, J. Pharmacol. Exp. Ther. 282 (2), 657-662, 1997.
65. Jiang, Q., Elson-Schwab, I., Courtemanche, C., and Ames, B.N., gamma-Tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells, Proc. Natl. Acad. Sci. U.S.A. 97 (21), 11494-11499, 2000.
66. Jiang, Q., Christen, S., Shigenaga, M.K., and Ames, B.N., gamma-Tocopherol, the major form of vitamin E in the US diet, deserves more attention, Am. J. Clin. Nutr. 74 (6), 714-722, 2001.
67. Jiang, Q. and Ames, B. N., gamma-Tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats, FASEB. J. 17 (8), 816-822, 2003.
68. Galli, F., Stabile, A.M., Betti, M., Conte, C., Pistilli, A., Rende, M., Floridi, A., and Azzi, A., The effect of alpha- and gamma-tocopherol and their carboxyethyl hydroxychroman metabolites on prostate cancer cell proliferation, Arch Biochem Biophys 423 (1), 97-102, 2004.
69. Thompson, T.A. and Wilding, G., Androgen antagonist activity by the antioxidant moiety of vitamin E, 2,2,5,7,8-pentamethyl-6-chromanol in human prostate carcinoma cells, Mol. Cancer. Ther. 2 (8), 797-803, 2003.
70. Hayashi, T., Kanetoshi, A., Nakamura, M., Tamura, M., and Shirahama, H., Reduction of alpha-tocopherolquinone to alpha-tocopherolhydroquinone in rat hepatocytes, Biochem. Pharmacol. 44 (3), 489-493, 1992.
71. Liebler, D.C., Kaysen, K.L., and Kennedy, T.A., Redox cycles of vitamin E: hydrolysis and ascorbic acid dependent reduction of 8a-(alkyldioxy)tocopherones, Biochemistry 28 (25), 9772-9777, 1989.
72. Bello, R.I., Kagan, V.E., Tyurin, V., Navarro, F., Alcain, F.J., and Villalba, J.M., Regeneration of lipophilic antioxidants by NAD(P)H: quinone oxidoreductase 1, Protoplasma 221 (1-2), 129-135, 2003.
73. Mukai, K., Itoh, S., and Morimoto, H., Stopped-flow kinetic study of vitamin E regeneration reaction with biological hydroquinones (reduced forms of ubiquinone, vitamin K, and tocopherolquinone) in solution, J Biol Chem 267 (31), 22277-22281, 1992.
74. Thornton, D.E., Jones, K.H., Jiang, Z., Zhang, H., Liu, G., and Cornwell, D.G., Antioxidant and cytotoxic tocopheryl quinones in normal and cancer cells, Free Radic. Biol. Med. 18 (6), 963-976, 1995.
75. Cornwell, D.G., Williams, M.V., Wani, A.A., Wani, G., Shen, E., and Jones, K.H., Mutagenicity of tocopheryl quinones: evolutionary advantage of selective accumulation of dietary alpha-tocopherol, Nutr. Cancer 43 (1), 111-118, 2002.
76. Calviello, G., Di Nicuolo, F., Piccioni, E., Marcocci, M.E., Serini, S., Maggiano, N., Jones, K.H., Cornwell, D.G., and Palozza, P., gamma-Tocopheryl quinone induces apoptosis in cancer cells via caspase-9 activation and cytochrome c release, Carcinogenesis 24 (3), 427-433, 2003.
77. Soo, C.C., Haqqani, A.S., Hidiroglou, N., Swanson, J.E., Parker, R.S., and Birnboim, H.C., Dose-dependent effects of dietary alpha- and gamma-tocopherols on genetic instability in mouse Mutatect tumors, J. Natl. Cancer Inst. 96 (10), 796-800, 2004.
78. Kempnà, P., Cipollone, R., Villacorta, L., Ricciarelli, R., and Zingg, J.M., Isoelectric point mobility shift assay for rapid screening of charged and uncharged ligands bound to proteins, IUBMB Life 55, 103-107, 2003.
79. Stocker, A. and Baumann, U., Supernatant protein factor in complex with RRR-alphatocopherylquinone: a link between oxidized Vitamin E and cholesterol biosynthesis, J. Mol. Biol. 332 (4), 759-765, 2003.
80. Panagabko, C., Morley, S., Hernandez, M., Cassolato, P., Gordon, H., Parsons, R., Manor, D., and Atkinson, J., Ligand specificity in the CRAL-TRIO protein family, Biochemistry 42 (21), 6467-6474, 2003.
81. Bauernfeind, J.B., Tocopherols in Food. Vitamin E. A Comprehensive Treatise, Marcel Dekker, I., New York and Basel, 1980, 99-167.
82. Bauernfeind, J.C., Rubin, S.H., Surmatis, J.D., and Ofner, A., Carotenoids and fatsoluble vitamins: contribution to food, feed and pharmaceuticals, Int. Z. Vitaminforsch. 40 (3), 391-416, 1970.
83. Traber, M.G. and Kayden, H.J., Vitamin E is delivered to cells via the high affinity receptor for low-density lipoprotein, Am. J. Clin. Nutr. 40 (4), 747-751, 1984.
84. Handelman, G.J., Epstein, W.L., Peerson, J., Spiegelman, D., Machlin, L.J., and Dratz, E.A., Human adipose alpha-tocopherol and gamma-tocopherol kinetics during and after 1 y of alpha-tocopherol supplementation, Am. J. Clin. Nutr. 59 (5), 1025-1032, 1994.
85. Hosomi, A., Arita, M., Sato, Y., Kiyose, C., Ueda, T., Igarashi, O., Arai, H., and Inoue, K., Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs, FEBS. Lett. 409 (1), 105-108, 1997.
86. Mardones, P. and Rigotti, A., Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease, J. Nutr. Biochem. 15 (5), 252-260, 2004.
87. Kolleck, I., Schlame, M., Fechner, H., Looman, A.C., Wissel, H., and Rustow, B., HDL is the major source of vitamin E for type II pneumocytes, Free Radic. Biol. Med. 27 (7-8), 882-890., 1999.
88. Goti, D., Hrzenjak, A., Levak-Frank, S., Frank, S., van Der Westhuyzen, D.R., Malle, E., and Sattler, W., Scavenger receptor class B, type I is expressed in porcine brain capillary endothelial cells and contributes to selective uptake of HDL- associated vitamin E, J. Neurochem. 76 (2), 498-508., 2001.
89. Goti, D., Reicher, H., Malle, E., Kostner, G.M., Panzenboeck, U., and Sattler, W., High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles, Biochem. J. 332 (Pt 1), 57-65, 1998.
90. Copp, R.P., Wisniewski, T., Hentati, F., Larnaout, A., Ben Hamida, M., and Kayden, H.J., Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders, Brain. Res. 822 (1-2), 80-87, 1999.
91. Yokota, T., Shiojiri, T., Gotoda, T., Arita, M., Arai, H., Ohga, T., Kanda, T., Suzuki, J., Imai, T., Matsumoto, H., Harino, S., Kiyosawa, M., Mizusawa, H., and Inoue, K., Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene, Ann. Neurol. 41 (6), 826-832, 1997.
92. Tamaru, Y., Hirano, M., Kusaka, H., Ito, H., Imai, T., and Ueno, S., alpha-Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia, Neurology 49 (2), 584-588, 1997.
93. Jishage, K., Arita, M., Igarashi, K., Iwata, T., Watanabe, M., Ogawa, M., Ueda, O., Kamada, N., Inoue, K., Arai, H., and Suzuki, H., Alpha-tocopherol transfer protein is important for the normal development of placental labyrinthine trophoblasts in mice, J. Biol. Chem. 276 (3), 1669-1672., 2001.
94. Federico, A., Ataxia with isolated vitamin E deficiency: a treatable neurologic disorder resembling Friedreich’s ataxia, Neurol. Sci. 25 (3), 119-121, 2004.
95. Traber, M.G., Burton, G.W., Ingold, K.U., and Kayden, H.J., RRR- and SRR-alphatocopherols are secreted without discrimination in human chylomicrons, but RRRalpha- tocopherol is preferentially secreted in very low density lipoproteins, J. Lipid. Res. 31 (4), 675-685, 1990.
96. Traber, M.G., Sokol, R.J., Kohlschutter, A., Yokota, T., Muller, D.P., Dufour, R., and Kayden, H.J., Impaired discrimination between stereoisomers of alpha-tocopherol in patients with familial isolated vitamin E deficiency, J. Lipid. Res. 34 (2), 201-210, 1993.
97. Hodis, H.N., Mack, W.J., LaBree, L., Mahrer, P.R., Sevanian, A., Liu, C.R., Liu, C.H., Hwang, J., Selzer, R.H., and Azen, S.P., Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS), Circulation 106 (12), 1453-1459, 2002.
98. Leonard, S.W., Terasawa, Y., Farese, R.V., Jr., and Traber, M.G., Incorporation of deuterated RRR- or all-rac-alpha-tocopherol in plasma and tissues of alpha-tocopherol transfer protein - null mice, Am. J. Clin. Nutr. 75 (3), 555-560, 2002.
99. Ham, A.J. and Liebler, D.C., Vitamin E oxidation in rat liver mitochondria, Biochemistry 34 (17), 5754-5761, 1995.
100. Tran, K. and Chan, A.C., Comparative uptake of alpha- and gamma-tocopherol by human endothelial cells, Lipids 27 (1), 38-41, 1992.
101. Catignani, G.L., An alpha-tocopherol binding protein in rat liver cytoplasm, Biochem. Biophys. Res. Commun. 67 (1), 66-72., 1975.
102. Dutta-Roy, A.K., Leishman, D.J., Gordon, M.J., Campbell, F.M., and Duthie, G.G., Identification of a low molecular mass (14.2 kDa) alpha-tocopherol-binding protein in the cytosol of rat liver and heart, Biochem. Biophys. Res. Commun. 196 (3), 1108-1112, 1993.
103. Dutta-Roy, A.K., Alpha-tocopherol-binding proteins: purification and characterization, Methods Enzymol. 282, 278-297, 1997.
104. Dutta-Roy, A.K., Molecular mechanism of cellular uptake and intracellular translocation of alpha-tocopherol: role of tocopherol-binding proteins, Food. Chem. Toxicol. 37 (9-10), 967-971, 1999.
105. Kaempf-Rotzoll, D.E., Traber, M.G., and Arai, H., Vitamin E and transfer proteins, Curr. Opin. Lipidol. 14 (3), 249-254, 2003.
106. Zimmer, S., Stocker, A., Sarbolouki, M.N., Spycher, S.E., Sassoon, J., and Azzi, A., A novel human tocopherol-associated protein: cloning, in vitro expression, and characterization, J. Biol. Chem. 275 (33), 25672-25680, 2000.
107. Shibata, N., Arita, M., Misaki, Y., Dohmae, N., Takio, K., Ono, T., Inoue, K., and Arai, H., Supernatant protein factor, which stimulates the conversion of squalene to lanosterol, is a cytosolic squalene transfer protein and enhances cholesterol biosynthesis, Proc. Natl. Acad. Sci. U.S.A. 98 (5), 2244-2249., 2001.
108. Bradford, A., Atkinson, J., Fuller, N., and Rand, R.P., The effect of vitamin E on the structure of membrane lipid assemblies, J. Lipid. Res., 44, 1940-1945, 2003.
109. Kempnà, P., Zingg, J.M., Ricciarelli, R., Hierl, M., Saxena, S., and Azzi, A., Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties, Free Radic. Biol. Med. 34, 1458-1472, 2003.
110. Anantharaman, V. and Aravind, L., The GOLD domain, a novel protein module involved in Golgi function and secretion, Genome Biol. 3 (5), research 0023, 2002.
111. Caras, I.W., Friedlander, E.J., and Bloch, K., Interactions of supernatant protein factor with components of the microsomal squalene epoxidase system. Binding of supernatant protein factor to anionic phospholipids, J. Biol. Chem. 255 (8), 3575-3580, 1980.
112. Azzi, A., Ricciarelli, R., and Zingg, J.M., Non-antioxidant molecular functions of alpha-tocopherol (vitamin E), FEBS Lett. 519 (1-3), 8-10, 2002.
113. Hacquebard, M. and Carpentier, Y.A., Vitamin E: absorption, plasma transport and cell uptake, Curr. Opin. Clin. Nutr. Metab. Care 8 (2), 133-138, 2005.
114. Oram, J.F., Vaughan, A.M., and Stocker, R., ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol, J. Biol. Chem. 276 (43), 39898-39902, 2001.
115. Halliwell, B., Rafter, J., and Jenner, A., Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am. J. Clin. Nutr. 81 (1 Suppl), 268S-276S, 2005.
116. Wang, X. and Quinn, P.J., The location and function of vitamin E in membranes (review), Mol. Membr. Biol. 17 (3), 143-156, 2000.
117. Yoshida, Y., Niki, E., and Noguchi, N., Comparative study on the action of tocopherols and tocotrienols as antioxidant: chemical and physical effects, Chem. Phys. Lipids 123 (1), 63-75, 2003.
118. Suzuki, Y.J., Tsuchiya, M., Wassall, S.R., Choo, Y.M., Govil, G., Kagan, V.E., and Packer, L., Structural and dynamic membrane properties of alpha-tocopherol and alpha-tocotrienol: implication to the molecular mechanism of their antioxidant potency, Biochemistry 32 (40), 10692-10699, 1993.
119. Pearce, B.C., Parker, R.A., Deason, M.E., Qureshi, A.A., and Wright, J.J., Hypocholesterolemic activity of synthetic and natural tocotrienols, J. Med. Chem. 35 (20), 3595-3606, 1992.
120. Parker, R.A., Pearce, B.C., Clark, R.W., Gordon, D.A., and Wright, J.J., Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, J. Biol. Chem. 268 (15), 11230-11238, 1993.
121. Wang, Q., Theriault, A., Gapor, A., and Adeli, K., Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway, Biochem. Biophys. Res. Commun. 246 (3), 640-643, 1998.
122. Khor, H.T. and Ng, T.T., Effects of administration of alpha-tocopherol and tocotrienols on serum lipids and liver HMG CoA reductase activity, Int. J. Food Sci. Nutr. 51 Suppl, S3-11, 2000.
123. Black, T.M., Wang, P., Maeda, N., and Coleman, R.A., Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation, J. Nutr. 130 (10), 2420-2426, 2000.
124. Khanna, S., Roy, S., Ryu, H., Bahadduri, P., Swaan, P.W., Ratan, R.R., and Sen, C.K., Molecular basis of vitamin E action. Tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration, J. Biol. Chem. 2003.
125. Das, S., Powell, S.R., Wang, P., Divald, A., Nesaretnam, K., Tosaki, A., Cordis, G.A., Maulik, N., and Das, D.K., Cardioprotection with palm tocotrienol: antioxidant activity of tocotrienol is linked with its ability to stabilize proteasomes, Am. J. Physiol. Heart Circ. Physiol., 289(1), H361-367, 2005.
126. Osakada, F., Hashino, A., Kume, T., Katsuki, H., Kaneko, S., and Akaike, A., Alphatocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons, Neuropharmacology 47 (6), 904-915, 2004.
127. Theriault, A., Chao, J.T., Wang, Q., Gapor, A., and Adeli, K., Tocotrienol: a review of its therapeutic potential, Clin. Biochem. 32 (5), 309-319, 1999.
128. Theriault, A., Chao, J.T., and Gapor, A., Tocotrienol is the most effective vitamin E for reducing endothelial expression of adhesion molecules and adhesion to monocytes, Atherosclerosis 160 (1), 21-30, 2002.
129. Noguchi, N., Hanyu, R., Nonaka, A., Okimoto, Y., and Kodama, T., Inhibition of THP-1 cell adhesion to endothelial cells by alpha-tocopherol and alpha-tocotrienol is dependent on intracellular concentration of the antioxidants, Free Radic. Biol. Med. 34 (12), 1614-1620, 2003.
130. Yu, W., Simmons-Menchaca, M., Gapor, A., Sanders, B.G., and Kline, K., Induction of apoptosis in human breast cancer cells by tocopherols and tocotrienols, Nutr. Cancer 33 (1), 26-32, 1999.
131. McIntyre, B.S., Briski, K.P., Tirmenstein, M.A., Fariss, M.W., Gapor, A., and Sylvester, P.W., Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells, Lipids 35 (2), 171-180, 2000.
132. McIntyre, B.S., Briski, K.P., Gapor, A., and Sylvester, P.W., Antiproliferative and apoptotic effects of tocopherols and tocotrienols on preneoplastic and neoplastic mouse mammary epithelial cells, Proc. Soc. Exp. Biol. Med. 224 (4), 292-301, 2000.
133. Sylvester, P.W., McIntyre, B.S., Gapor, A., and Briski, K.P., Vitamin E inhibition of normal mammary epithelial cell growth is associated with a reduction in protein kinase C(alpha) activation, Cell. Prolif. 34 (6), 347-357, 2001.
134. Komiyama, K., Iizuka, K., Yamaoka, M., Watanabe, H., Tsuchiya, N., and Umezawa, I., Studies on the biological activity of tocotrienols, Chem. Pharm. Bull. (Tokyo) 37 (5), 1369-1371, 1989.
135. Sylvester, P.W. and Shah, S.J., Mechanisms mediating the antiproliferative and apoptotic effects of vitamin E in mammary cancer cells, Front Biosci. 10, 699-709, 2005.
136. Sies, H., Oxidative stress: oxidants and antioxidants, Exp. Physiol. 82 (2), 291-295, 1997.
137. Meydani, M., Vitamin E and atherosclerosis: beyond prevention of LDL oxidation, J. Nutr. 131 (2), 366S-368S, 2001.
138. Jialal, I., Devaraj, S., and Kaul, N., The effect of alpha-tocopherol on monocyte proatherogenic activity, J. Nutr. 131 (2), 389S-394S, 2001.
139. Packer, L., Weber, S.U., and Rimbach, G., Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling, J. Nutr. 131 (2), 369S-373S., 2001.
140. Mashima, R., Witting, P.K., and Stocker, R., Oxidants and antioxidants in atherosclerosis, Curr. Opin. Lipidol. 12 (4), 411-418, 2001.
141. Asplund, K., Antioxidant vitamins in the prevention of cardiovascular disease: a systematic review, J. Intern. Med. 251 (5), 372-392, 2002.
142. Upston, J.M., Kritharides, L., and Stocker, R., The role of vitamin E in atherosclerosis, Prog. Lipid. Res. 42 (5), 405-422, 2003.
143. Traber, M.G. and Packer, L., Vitamin E: beyond antioxidant function, Am. J. Clin. Nutr. 62 (6 Suppl), 1501S-1509S, 1995.
144. Boscoboinik, D., Szewczyk, A., Hensey, C., and Azzi, A., Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C, J. Biol. Chem. 266 (10), 6188-6194, 1991.
145. Ricciarelli, R., Tasinato, A., Clement, S., Ozer, N.K., Boscoboinik, D., and Azzi, A., alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state, Biochem. J. 334 (Pt1), 243-249, 1998.
146. Ricciarelli, R. and Azzi, A., Regulation of recombinant PKC alpha activity by protein phosphatase 1 and protein phosphatase 2A, Arch. Biochem. Biophys. 355 (2), 197-200, 1998.
147. Shah, S.J. and Sylvester, P.W., Gamma-tocotrienol inhibits neoplastic mammary epithelial cell proliferation by decreasing Akt and nuclear factor kappaB activity, Exp. Biol. Med. (Maywood) 230 (4), 235-241, 2005.
148. Pentland, A.P., Morrison, A.R., Jacobs, S.C., Hruza, L.L., Hebert, J.S., and Packer, L., Tocopherol analogs suppress arachidonic acid metabolism via phospholipase inhibition, J. Biol. Chem. 267 (22), 15578-15584, 1992.
149. Abate, A., Yang, G., Dennery, P.A., Oberle, S., and Schroder, H., Synergistic inhibition of cyclooxygenase-2 expression by vitamin E and aspirin, Free Radic. Biol. Med. 29 (11), 1135-1142, 2000.
150. Chandra, V., Jasti, J., Kaur, P., Betzel, C., Srinivasan, A., and Singh, T.P., First structural evidence of a specific inhibition of phospholipase A2 by alpha-tocopherol (vitamin E) and its implications in inflammation: crystal structure of the complex formed between phospholipase A2 and alpha-tocopherol at 1.8 A resolution, J. Mol. Biol. 320 (2), 215-222, 2002.
151. Min, J., Guo, J., Zhao, F., and Cai, D., Effect of apoptosis induced by different vitamin E homologous analogues in human hepatoma cells (HepG2), Wei Sheng Yan Jiu 32 (2), 131-133, 2003.
152. Azzi, A., Gysin, R., Kempna, P., Ricciarelli, R., Villacorta, L., Visarius, T., and Zingg, J.M., Regulation of gene and protein expression by vitamin E, Free Radic. Res. 36 (1), 30-35, 2002.
153. Landes, N., Pfluger, P., Kluth, D., Birringer, M., Ruhl, R., Bol, G.F., Glatt, H., and Brigelius-Flohe, R., Vitamin E activates gene expression via the pregnane X receptor, Biochem. Pharmacol. 65 (2), 269-273, 2003.
154. Yamauchi, J., Iwamoto, T., Kida, S., Masushige, S., Yamada, K., and Esashi, T., Tocopherol-associated protein is a ligand-dependent transcriptional activator, Biochem. Biophys. Res. Commun. 285 (2), 295-299., 2001.
155. Campbell, S.E., Stone, W.L., Whaley, S.G., Qui, M., and Krishnan, K., Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines, BMC Cancer 3 (1), 25, 2003.
156. Traber, M.G., Vitamin E, nuclear receptors and xenobiotic metabolism, Arch. Biochem. Biophys. 423 (1), 6-11, 2004.
157. Gimeno, A., Zaragoza, R., Vina, J.R., and Miralles, V.J., Vitamin E activates CRABPII gene expression in cultured human fibroblasts, role of protein kinase C, FEBS Lett 569 (1-3), 240-244, 2004.
158. Stauble, B., Boscoboinik, D., Tasinato, A., and Azzi, A., Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells, Eur. J. Biochem. 226 (2), 393-402, 1994.
159. Azzi, A., Boscoboinik, D., Marilley, D., Ozer, N.K., Stauble, B., and Tasinato, A., Vitamin E: a sensor and an information transducer of the cell oxidation state, Am. J. Clin. Nutr. 62 (6 Suppl), 1337S-1346S, 1995.
160. Yokota, T., Uchihara, T., Kumagai, J., Shiojiri, T., Pang, J.J., Arita, M., Arai, H., Hayashi, M., Kiyosawa, M., Okeda, R., and Mizusawa, H., Postmortem study of ataxia with retinitis pigmentosa by mutation of the alpha-tocopherol transfer protein gene, J. Neurol. Neurosurg. Psychiatry 68 (4), 521-525, 2000.
161. Jauslin, M.L., Meier, T., Smith, R.A., and Murphy, M.P., Mitochondria-targeted antioxidants protect Friedreich ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants, Faseb J 17 (13), 1972-1974, 2003.
162. Hart, P.E., Lodi, R., Rajagopalan, B., Bradley, J.L., Crilley, J. G., Turner, C., Blamire, A.M., Manners, D., Styles, P., Schapira, A.H., and Cooper, J.M., Antioxidant treatment of patients with Friedreich ataxia: four-year follow-up, Arch Neurol 62 (4), 621-626, 2005.
163. Meydani, M., Koga, T., and Ali, S., Vitamin E deficiency, in Encyclopedia of Life Sciences, Nature Publishing Group, 2001, 1-6.
164. Salonen, J.T., Nyyssonen, K., Salonen, R., Lakka, H.M., Kaikkonen, J., Porkkala-Sarataho, E., Voutilainen, S., Lakka, T.A., Rissanen, T., Leskinen, L., Tuomainen, T.P., Valkonen, V.P., Ristonmaa, U., and Poulsen, H.E., Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis, J. Intern. Med. 248 (5), 377-386., 2000.
165. Kaul, N., Devaraj, S., and Jialal, I., Alpha-tocopherol and atherosclerosis, Exp. Biol. Med. (Maywood) 226 (1), 5-12, 2001.
166. Azzi, A., Gysin, R., Kempna, P., Ricciarelli, R., Villacorta, L., Visarius, T., and Zingg, J.M., The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events, Mol. Aspects Med. 24 (6), 325-336, 2003.
167. Munteanu, A., Zingg, J.M., and Azzi, A., Anti-atherosclerotic effects of vitamin E - myth or reality? J. Cell Mol. Med. 8 (1), 59-76, 2004.
168. Hathcock, J.N., Azzi, A., Blumberg, J., Bray, T., Dickinson, A., Frei, B., Jialal, I., Johnston, C.S., Kelly, F.J., Kraemer, K., Packer, L., Parthasarathy, S., Sies, H., and Traber, M.G., Vitamins E and C are safe across a broad range of intakes, Am. J. Clin. Nutr. 81 (4), 736-745, 2005.
169. Brown, B.G. and Crowley, J., Is there any hope for vitamin E?, Jama 293 (11), 1387-1390, 2005.
170. Lonn, E., Bosch, J., Yusuf, S., Sheridan, P., Pogue, J., Arnold, J.M., Ross, C., Arnold, A., Sleight, P., Probstfield, J., and Dagenais, G.R., Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial, JAMA 293 (11), 1338-1347, 2005.
171. Albanes, D., Heinonen, O.P., Huttunen, J.K., Taylor, P.R., Virtamo, J., Edwards, B.K., Haapakoski, J., Rautalahti, M., Hartman, A.M., Palmgren, J. et al., Effects of alphatocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study, Am. J. Clin. Nutr. 62 (6 Suppl), 1427S-1430S, 1995.
172. Woodson, K., Tangrea, J.A., Barrett, M.J., Virtamo, J., Taylor, P.R., and Albanes, D., Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers, J. Natl. Cancer. Inst. 91 (20), 1738-1743, 1999.
173. Leppala, J.M., Virtamo, J., Fogelholm, R., Huttunen, J.K., Albanes, D., Taylor, P.R., and Heinonen, O.P., Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers, Arterioscler. Thromb. Vasc. Biol. 20 (1), 230-235, 2000.
174. Albanes, D., Malila, N., Taylor, P.R., Huttunen, J.K., Virtamo, J., Edwards, B.K., Rautalahti, M., Hartman, A.M., Barrett, M.J., Pietinen, P., Hartman, T.J., Sipponen, P., Lewin, K., Teerenhovi, L., Hietanen, P., Tangrea, J.A., Virtanen, M., and Heinonen, O.P., Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland), Cancer Causes Control 11 (3), 197-205, 2000.
175. Giovannucci, E., Gamma-tocopherol: a new player in prostate cancer prevention? J. Natl. Cancer Inst. 92 (24), 1966-1967, 2000.
176. Houglum, K., Venkataramani, A., Lyche, K., and Chojkier, M., A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C, Gastroenterology 113 (4), 1069-1073, 1997.
177. Harrison, S.A., Torgerson, S., Hayashi, P., Ward, J., and Schenker, S., Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis, Am J Gastroenterol 98 (11), 2485-2490, 2003.
178. Berman, K. and Brodaty, H., Tocopherol (vitamin E) in Alzheimer’s disease and other neurodegenerative disorders, CNS Drugs 18 (12), 807-825, 2004.
179. Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L., Wilson, R.S., Aggarwal, N.T., and Scherr, P. A., Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change, Am. J. Clin. Nutr. 81 (2), 508-514, 2005.
180. Fariss, M.W. and Zhang, J.G., Vitamin E therapy in Parkinson’s disease, Toxicology 189 (1-2), 129-46, 2003.
181. Doring, F., Rimbach, G., and Lodge, J.K., In silico search for single nucleotide polymorphisms in genes important in vitamin E homeostasis, IUBMB Life 56 (10), 615-620, 2004.
182. Barbeau, A., Friedreich’s ataxia 1980. An overview of the physiopathology, Can. J. Neurol. Sci. 7 (4), 455-468, 1980.
183. Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R.L., Atwood, C.S., Johnson, A.B., Kress, Y., Vinters, H.V., Tabaton, M., Shimohama, S., Cash, A.D., Siedlak, S.L., Harris, P.L., Jones, P.K., Petersen, R.B., Perry, G., and Smith, M.A., Mitochondrial abnormalities in Alzheimer’s disease, J. Neurosci. 21 (9), 3017-3023, 2001.
184. Kaplan, J., Spinocerebellar ataxias due to mitochondrial defects, Neurochem. Int. 40 (6), 553-557, 2002.
185. Marriage, B., Cladinin, M.T., and Glerum, D.M., Nutritional cofactor treatment in mitochondrial disorders, J. Am. Diet. Assoc. 103 (8), 1029-1038, 2003.
186. Dial, S. and Eitenmiller, R.R., Tocopherols and tocotrienols in key foods in the U.S. diet, in Nutrition, Lipids, Health, and Disease, Ong, A.S.F., Niki, E., and Packer, L., Eds., AOCS Press, 1995, 327-342.
187. Fuchs, J., Weber, S., Podda, M., Groth, N., Herrling, T., Packer, L., and Kaufmann, R., HPLC analysis of vitamin E isoforms in human epidermis: correlation with minimal erythema dose and free radical scavenging activity, Free Radic. Biol. Med. 34 (3), 330-336, 2003.
188. Bjorneboe, A., Bjorneboe, G.E., and Drevon, C.A., Serum half-life, distribution, hepatic uptake and biliary excretion of alpha-tocopherol in rats, Biochim. Biophys. Acta 921 (2), 175-181, 1987.
189. Mustacich, D.J., Shields, J., Horton, R.A., Brown, M.K., and Reed, D.J., Biliary secretion of alpha-tocopherol and the role of the mdr2 P-glycoprotein in rats and mice, Arch. Biochem. Biophys. 350 (2), 183-192, 1998.
190. Traber, M.G. and Arai, H., Molecular mechanisms of vitamin E transport, Annu. Rev. Nutr. 19, 343-355, 1999.
191. Caras, I.W. and Bloch, K., Effects of a supernatant protein activator on microsomal squalene-2,3-oxide-lanosterol cyclase, J. Biol. Chem. 254 (23), 11816-11821, 1979.
192. Porter, T.D., Supernatant protein factor and tocopherol-associated protein: an unexpected link between cholesterol synthesis and vitamin E (review), J. Nutr. Biochem. 14 (1), 3-6, 2003.
193. Heiser, M., Hutter-Paier, B., Jerkovic, L., Pfragner, R., Windisch, M., Becker-Andre, M., and Dieplinger, H., Vitamin E binding protein afamin protects neuronal cells in vitro, J. Neural. Transm. Suppl. (62), 337-345, 2002.
194. Voegele, A.F., Jerkovic, L., Wellenzohn, B., Eller, P., Kronenberg, F., Liedl, K.R., and Dieplinger, H., Characterization of the vitamin E-binding properties of human plasma afamin, Biochemistry 41 (49), 14532-14538, 2002.
195. Cavalier, L., Ouahchi, K., Kayden, H.J., Di Donato, S., Reutenauer, L., Mandel, J.L., and Koenig, M., Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families, Am. J. Hum. Genet. 62 (2), 301-310, 1998.
196. Benomar, A., Yahyaoui, M., Marzouki, N., Birouk, N., Bouslam, N., Belaidi, H., Amarti, A., Ouazzani, R., and Chkili, T., Vitamin E deficiency ataxia associated with adenoma, J. Neurol. Sci. 162 (1), 97-101., 1999.
197. Bowry, V.W., Ingold, K.U., and Stocker, R., Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant, Biochem. J. 288 (Pt 2), 341-344, 1992.
198. Upston, J.M., Terentis, A.C., and Stocker, R., Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement, FASEB. J. 13 (9), 977-994., 1999.
199. Wolf, G., gamma-Tocopherol: an efficient protector of lipids against nitric oxideinitiated peroxidative damage, Nutr. Rev. 55 (10), 376-378, 1997.
200. Christen, S., Woodall, A.A., Shigenaga, M.K., Southwell-Keely, P.T., Duncan, M.W., and Ames, B. N., Gamma-tocopherol traps mutagenic electrophiles such as NO(X) and complements alpha-tocopherol: physiological implications, Proc. Natl. Acad. Sci. U.S.A. 94 (7), 3217-3222., 1997.
201. Goss, S.P., Hogg, N., and Kalyanaraman, B., The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite, Arch. Biochem. Biophys. 363 (2), 333-340, 1999.
202. Sen, C.K., Khanna, S., Roy, S., and Packer, L., Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells, J. Biol. Chem. 275 (17), 13049-13055, 2000.
203. Venugopal, S.K., Devaraj, S., and Jialal, I., RRR-alpha-tocopherol decreases the expression of the major scavenger receptor, CD36, in human macrophages via inhibition of tyrosine kinase (Tyk2), Atherosclerosis 175 (2), 213-220, 2004.
204. Tran, K. and Chan, A.C., R, R, R-alpha-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule, Biochim. Biophys. Acta 1043 (2), 189-197, 1990.
205. Devaraj, S. and Jialal, I., Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase, Arterioscler. Thromb. Vasc. Biol. 19 (4), 1125-1133., 1999.
206. van Haaften, R.I., Haenen, G.R., van Bladeren, P.J., Bogaards, J.J., Evelo, C.T., and Bast, A., Inhibition of various glutathione S-transferase isoenzymes by RRR-alphatocopherol, Toxicol. in Vitro 17 (3), 245-251, 2003.
207. Cachia, O., Benna, J.E., Pedruzzi, E., Descomps, B., Gougerot-Pocidalo, M.A., and Leger, C.L., Alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation, J. Biol. Chem. 273 (49), 32801-32805, 1998.
208. Gohil, K., Schock, B.C., Chakraborty, A.A., Terasawa, Y., Raber, J., Farese, R.V., Jr., Packer, L., Cross, C.E., and Traber, M.G., Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein, Free Radic. Biol. Med. 35 (11), 1343-1354, 2003.
209. Barella, L., Muller, P.Y., Schlachter, M., Hunziker, W., Stocklin, E., Spitzer, V., Meier, N., de Pascual-Teresa, S., Minihane, A. M., and Rimbach, G., Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in rats, Biochim. Biophys. Acta 1689 (1), 66-74, 2004.